Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("non-nucleoside reverse transcriptase inhibitors")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 98

  • Page / 4
Export

Selection :

  • and

Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageableSEDEN, Kay; BACK, David; KHOO, Saye et al.Journal of antimicrobial chemotherapy (Print). 2009, Vol 64, Num 1, pp 5-8, issn 0305-7453, 4 p.Article

Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitnessBANGSBERG, David R; ACOSTA, Edward P; GUPTA, Reena et al.AIDS (London). 2006, Vol 20, Num 2, pp 223-231, issn 0269-9370, 9 p.Article

Shifting paradigms : the resistance profile of etravirineGERETTI, Anna Maria.Journal of antimicrobial chemotherapy (Print). 2008, Vol 62, Num 4, pp 643-647, issn 0305-7453, 5 p.Article

Managing antiretroviral-associated liver diseaseDIETERICH, Douglas.Journal of acquired immune deficiency syndromes (1999). 2003, Vol 34, pp S34-S39, issn 1525-4135, SUP1Conference Paper

No pol Mutation is Associated Independently with the Lack of Immune Recovery in Patients Infected with HIV and Failing Antiretroviral TherapyGIANOTTI, Nicola; GALLI, Laura; DI GIAMBENEDETTO, Simona et al.Journal of medical virology. 2011, Vol 83, Num 3, pp 391-398, issn 0146-6615, 8 p.Article

Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patientsROTGER, Margalida; COLOMBO, Sara; FURRER, Hansjakob et al.Pharmacogenetics (London). 2005, Vol 15, Num 1, pp 1-5, issn 0960-314X, 5 p.Article

A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcomaPORTSMOUTH, Simon; STEBBING, Justin; GILL, Jas et al.AIDS (London). 2003, Vol 17, Num 11, pp F17-F22, issn 0269-9370Article

Comparison of the induction of P-glycoprotein activity by nucleotide, nucleoside, and non-nucleoside reverse transcriptase inhibitorsWEISS, Johanna; WEIS, Nicola; KETABI-KIYANVASH, Nahal et al.European journal of pharmacology. 2008, Vol 579, Num 1-3, pp 104-109, issn 0014-2999, 6 p.Article

Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimenFOX, Zoe; PHILLIPS, Andrew; COHERE, Cal et al.AIDS (London). 2008, Vol 22, Num 17, pp 2279-2289, issn 0269-9370, 11 p.Article

N'-[2-(2-thiophene) ethyl]-N'[2-(5-bromopyridyl)]thiourea (HI-443), a rationally designed non-nucleoside reverse transcriptase inhibitor compound with potent anti-HIV activityUCKUN, Fatih M; QAZI, Sanjive; VENKATACHALAM, Taracad et al.Arzneimittel-Forschung. 2007, Vol 57, Num 5, pp 278-285, issn 0004-4172, 8 p.Article

Etravirine for the treatment of HIV/AIDSSCHRIJVERS, Rik.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 8, pp 1087-1096, issn 1465-6566, 10 p.Article

Pharmacogenetics of Anti-HIV DrugsTELENTI, A; ZANGER, U. M.Annual review of pharmacology and toxicology. 2008, Vol 48, pp 227-256, issn 0362-1642, 30 p.Article

Modulation of human BCRP (ABCG2) activity by anti-HIV drugsWEISS, Johanna; ROSE, Johanna; HENRIKE STORCH, Caroline et al.Journal of antimicrobial chemotherapy (Print). 2007, Vol 59, Num 2, pp 238-245, issn 0305-7453, 8 p.Article

Intracellular and plasma pharmacokinetics of efavirenz in HIV-infected individualsALMOND, Lisa M; HOGGARD, Patrick G; EDIRISINGHE, Damitha et al.Journal of antimicrobial chemotherapy (Print). 2005, Vol 56, Num 4, pp 738-744, issn 0305-7453, 7 p.Article

Prevalence of etravirine-associated mutations in clinical samples with resistance to nevirapine and efavirenzLLIBRE, J. M; SANTOS, J. R; PUIG, T et al.Journal of antimicrobial chemotherapy (Print). 2008, Vol 62, Num 5, pp 909-913, issn 0305-7453, 5 p.Article

Nevirapine use in HIV-1-infected childrenVERWEEL, Gwenda; SHARLAND, Mike; LYALL, Hermione et al.AIDS (London). 2003, Vol 17, Num 11, pp 1639-1647, issn 0269-9370, 9 p.Article

Structure-activity relationship studies on a novel family of specific HIV-1 reverse transcriptase inhibitorsBONACHE, Maria-Cruz; CHAMORRO, Cristina; LOBATON, Esther et al.Antiviral chemistry & chemotherapy. 2003, Vol 14, Num 5, pp 249-262, issn 0956-3202, 14 p.Article

Dawn of non-nucleoside inhibitor-based anti-HIV microbicidesD'CRUZ, Osmond J; UCKUN, Fatih M.Journal of antimicrobial chemotherapy (Print). 2006, Vol 57, Num 3, pp 411-423, issn 0305-7453, 13 p.Article

Lack of an effect of rilpivirine on the pharmacokinetics of ethinylestradiol and norethindrone in healthy volunteersCRAUWELS, Herta M; VAN HEESWIJK, Rolf P. G; BUELENS, Annemie et al.International journal of clinical pharmacology and therapeutics. 2014, Vol 52, Num 2, pp 118-128, issn 0946-1965, 11 p.Article

Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimenFISCHL, Margaret A; COLLIER, Ann C; BASSETT, Roland et al.AIDS (London). 2007, Vol 21, Num 3, pp 325-333, issn 0269-9370, 9 p.Article

In vivo pharmacokinetics and toxicity of a novel hydrophilic oral formulation of the potent non-nucleoside reverse transcriptase inhibitor compound N'-[2-(2 -thiophene )ethyl] -N'-[2 -(5-bromopyridyl)]-thiourea (HI-443)UCKUNL, Fatih M; TIBBLES, Heather; ERBECK, Douglas et al.Arzneimittel-Forschung. 2007, Vol 57, Num 4, pp 218-226, issn 0004-4172, 9 p.Article

Short-term antiviral activity of TMC278 : a novel NNRTI - in treatment-naive HIV-1-infected subjectsGOEBEL, Frank; YAKOVLEV, Alexy; POZNIAK, Anton L et al.AIDS (London). 2006, Vol 20, Num 13, pp 1721-1726, issn 0269-9370, 6 p.Article

Carrageenan/MIV-150 (PC-815), a combination microbicideFERNANDEZ-ROMERO, José A; THORN, Mitchell; HARTMAN, Tracy L et al.Sexually transmitted diseases. 2007, Vol 34, Num 1, pp 9-14, issn 0148-5717, 6 p.Article

Improved oral bioavailability of anti-HIV agent N'-[2-(2-thiophene)ethyl] -N'-[2-(5-bromopyridyl)]-thiourea (HI-443) in a novel lipophilic formulationUCKUN, Fatih M; ERBECK, Douglas; TIBBLES, Heather et al.Arzneimittel-Forschung. 2007, Vol 57, Num 3, pp 164-170, issn 0004-4172, 7 p.Article

Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapyPALMER, Sarah; BOLTZ, Valerie; MELLORS, John W et al.AIDS (London). 2006, Vol 20, Num 5, pp 701-710, issn 0269-9370, 10 p.Article

  • Page / 4